Key result
Complex stenting of coronary bifurcation lesions yielded similar rates of major cardiovascular events and definite stent thrombosis compared to simple stenting at 14 months.
Why the study?
Does a complex stenting strategy reduce stent thrombosis and major adverse cardiac events compared to a simple stenting strategy in patients with coronary bifurcation lesions?
RCT (n=413)
Yes
Does a complex stenting strategy reduce stent thrombosis and major adverse cardiac events compared to a simple stenting strategy in patients with coronary bifurcation lesions?
At 14 months, simple and complex stenting strategies for coronary bifurcation lesions using sirolimus-eluting stents showed similarly low rates of stent thrombosis and MACE.
Answers are grounded in this paper and cite their sources.
Simple stenting suffices for bifurcation lesions; confirms no MACE or thrombosis benefit from complex techniques in this RCT.
AIMS: The risk of stent thrombosis has been reported to increase with percutaneous coronary intervention (PCI) complexity. The present study reports the pre-specified secondary endpoint of a 14-month stent thrombosis and major adverse cardiac events in patients stented with a simple versus a complex bifurcation technique using sirolimus eluting stents (SES). METHODS AND RESULTS: A total of 413 patients with a coronary bifurcation lesion were randomised to a simple treatment strategy; stenting of main vessel and optional stenting of side branch (MV group), or to a complex stenting strategy; stenting of both main vessel and side branch (MV+SB group). Mortality data were available in all patients and 14-month clinical follow-up data in 395 (96%) of the patients. After 14 months, the rates of definite, probable and possible stent thrombosis (ARC criteria) were 1.0% vs. 0.5%, 1.0% vs. 0% and 0.5% vs. 0% (ns) in the MV and in the MV+SB groups, respectively. Rates of MACE were 9.5% in the MV group and 8.2% in the MV+SB group (ns). Total death was seen in 2.4% vs. 1.0% and non-PCI related myocardial infarction in 2.0% vs. 1.0% in the MV and the MV+SB groups, respectively. CONCLUSIONS: After 14 months, two months after recommended cessation of dual antiplatelet therapy, the rates of stent thrombosis and major adverse cardiac events were low and independent of treatment complexity in patients treated with SES for coronary artery bifurcation lesions.
No takes yet. Share an insight, caveat, or question.
Galløe et al. (2008) conducted an RCT in Coronary artery bifurcation lesions (n=413). Complex stenting strategy (main vessel and side branch) vs. Simple stenting strategy (main vessel and optional side branch) was evaluated on Major adverse cardiac events (MACE) (p=ns). Complex stenting of coronary bifurcation lesions yielded similar rates of major cardiovascular events and definite stent thrombosis compared to simple stenting at 14 months.
Synapse has enriched 10 related papers. Consider them for comparative context: